Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Children With Achondroplasia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating recombinant human growth hormone in children with achondroplasia to assess efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Achondroplasia

Drugs mentioned

• Recombinant human growth hormone (somatropin)

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Achondroplasia | Phase 4 | Status: UNKNOWN